SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-14-000398
Filing Date
2014-05-01
Accepted
2014-05-01 19:43:47
Documents
1
Period of Report
2014-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 11323
  Complete submission text file 0000904454-14-000398.txt   13380
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1212
Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 14806604
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 14806603

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations